From Infection to Immunity: Understanding the Response to SARS-CoV2 Through In-Silico Modeling
Background
Immune system conditions of the patient is a key factor in COVID-19 infection survival. A growing number of studies have focused on immunological determinants to develop better biomarkers for therapies.
Aim
Studies of the insurgence of immunity is at the core of both SARS-CoV-2 vaccine development and therapies. This paper attempts to describe the insurgence (and the span) of immunity in COVID-19 at the population level by developing an in-silico model. We simulate the immune response to SARS-CoV-2 and analyze the impact of infecting viral load, affinity to the ACE2 receptor, and age in an artificially infected population on the course of the disease.
Methods
We use a stochastic agent-based immune simulation platform to construct a virtual cohort of infected individuals with age-dependent varying degrees of immune competence. We use a parameter set to reproduce known inter-patient variability and general epidemiological statistics.
Results
By assuming the viremia at day 30 of the infection to be the proxy for lethality, we reproduce in-silico several clinical observations and identify critical factors in the statistical evolution of the infection. In particular, we evidence the importance of the humoral response over the cytotoxic response and find that the antibody titers measured after day 25 from the infection are a prognostic factor for determining the clinical outcome of the infection. Our modeling framework uses COVID-19 infection to demonstrate the actionable effectiveness of modeling the immune response at individual and population levels. The model developed can explain and interpret observed patterns of infection and makes verifiable temporal predictions. Within the limitations imposed by the simulated environment, this work proposes quantitatively that the great variability observed in the patient outcomes in real life can be the mere result of subtle variability in the infecting viral load and immune competence in the population. In this work, we exemplify how computational modeling of immune response provides an important view to discuss hypothesis and design new experiments, in particular paving the way to further investigations about the duration of vaccine-elicited immunity especially in the view of the blundering effect of immunosenescence.
Top-30
Journals
|
1
2
3
4
5
|
|
|
Frontiers in Immunology
5 publications, 9.43%
|
|
|
Journal of Biomolecular Structure and Dynamics
4 publications, 7.55%
|
|
|
Journal of Genetic Engineering and Biotechnology
4 publications, 7.55%
|
|
|
Scientific Reports
3 publications, 5.66%
|
|
|
Vaccines
2 publications, 3.77%
|
|
|
Frontiers in Molecular Biosciences
2 publications, 3.77%
|
|
|
Computers in Biology and Medicine
2 publications, 3.77%
|
|
|
International Journal of Biological Macromolecules
2 publications, 3.77%
|
|
|
Pharmaceutics
1 publication, 1.89%
|
|
|
Frontiers in Medicine
1 publication, 1.89%
|
|
|
International Journal of Peptide Research and Therapeutics
1 publication, 1.89%
|
|
|
Beni-Suef University Journal of Basic and Applied Sciences
1 publication, 1.89%
|
|
|
Systems Research and Behavioral Science
1 publication, 1.89%
|
|
|
Cellular Signalling
1 publication, 1.89%
|
|
|
Genes and Genomics
1 publication, 1.89%
|
|
|
Chaos, Solitons and Fractals
1 publication, 1.89%
|
|
|
Frontiers in Microbiology
1 publication, 1.89%
|
|
|
Open Biology
1 publication, 1.89%
|
|
|
Heliyon
1 publication, 1.89%
|
|
|
PLoS Computational Biology
1 publication, 1.89%
|
|
|
PLoS Pathogens
1 publication, 1.89%
|
|
|
Pharmaceuticals
1 publication, 1.89%
|
|
|
Entropy
1 publication, 1.89%
|
|
|
Computational Biology and Chemistry
1 publication, 1.89%
|
|
|
PLoS ONE
1 publication, 1.89%
|
|
|
mSphere
1 publication, 1.89%
|
|
|
Current Proteomics
1 publication, 1.89%
|
|
|
Biochemistry and Biophysics Reports
1 publication, 1.89%
|
|
|
International Journal of Molecular Sciences
1 publication, 1.89%
|
|
|
1
2
3
4
5
|
Publishers
|
2
4
6
8
10
12
14
16
|
|
|
Elsevier
15 publications, 28.3%
|
|
|
Frontiers Media S.A.
9 publications, 16.98%
|
|
|
MDPI
6 publications, 11.32%
|
|
|
Springer Nature
6 publications, 11.32%
|
|
|
Taylor & Francis
4 publications, 7.55%
|
|
|
Public Library of Science (PLoS)
3 publications, 5.66%
|
|
|
Wiley
2 publications, 3.77%
|
|
|
Institute of Electrical and Electronics Engineers (IEEE)
2 publications, 3.77%
|
|
|
Cold Spring Harbor Laboratory
2 publications, 3.77%
|
|
|
The Korean Society of Genetics
1 publication, 1.89%
|
|
|
The Royal Society
1 publication, 1.89%
|
|
|
American Society for Microbiology
1 publication, 1.89%
|
|
|
Apex Publishing
1 publication, 1.89%
|
|
|
2
4
6
8
10
12
14
16
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.